Loading clinical trials...

COMPLETEDNANCT00606294

Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

The main purpose of this study is to evaluate low oxygen areas called hypoxia within tumors. These low oxygen areas are thought to be the reason why tumors are more resistant to chemotherapy and radia...

Lead sponsor: Memorial Sloan Kettering Cancer Center•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760 · Solid Tumor, Advanced Cancer, and more

RECRUITINGPhase 2/3

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663 · Solid Tumor, Solid Carcinoma, and more

RECRUITING

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

RECRUITINGPhase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more

RECRUITINGPhase 2

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

NCT06477692 · Head and Neck Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 28, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment216

Start dateJun 2004

Last updatedJun 28, 2023

Condition

Head and Neck Cancer

Locations shown

Memorial Sloan Kettering Cancer Center at Basking Ridge

Basking Ridge, New Jersey

Memorial Sloan Kettering Cancer Center at Commack

Commack, New York

Memorial Sloan Kettering Westchester

Harrison, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 28, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions